(19)
(11) EP 2 155 114 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.05.2020 Bulletin 2020/21

(45) Mention of the grant of the patent:
08.04.2020 Bulletin 2020/15

(21) Application number: 08768102.9

(22) Date of filing: 04.06.2008
(51) International Patent Classification (IPC): 
A61F 2/24(2006.01)
(86) International application number:
PCT/US2008/007015
(87) International publication number:
WO 2008/150529 (11.12.2008 Gazette 2008/50)

(54)

PROSTHETIC HEART VALVES

HERZKLAPPENPROTHESEN

VALVULES CARDIAQUES PROTHÉTIQUES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

(30) Priority: 04.06.2007 US 933274 P

(43) Date of publication of application:
24.02.2010 Bulletin 2010/08

(60) Divisional application:
13187880.3 / 2698129

(73) Proprietor: St. Jude Medical, LLC
Abbott Park, IL 60064 (US)

(72) Inventors:
  • BRAIDO, Peter N.
    Wyoming, MN 55092 (US)
  • ALKHATIB, Yousef, F.
    Maple Grove, Minnesota 55369 (US)

(74) Representative: Gill Jennings & Every LLP 
The Broadgate Tower 20 Primrose Street
London EC2A 2ES
London EC2A 2ES (GB)


(56) References cited: : 
EP-A- 1 690 515
WO-A-2008/028569
US-A1- 2005 137 690
US-A1- 2006 122 686
US-A1- 2006 259 137
 WO-A-2006/127765
US-A1- 2002 138 138
US-A1- 2005 234 546
US-A1- 2006 122 692
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).